Samson W. Fine

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 16 papers. Top paper: “Predictors for post-treatment biopsy outcomes after prostate stereotactic body radiotherapy”.

Predictors for post-treatment biopsy outcomes after prostate stereotactic body radiotherapy

Radiotherapy and Oncology(2021)10.1016/j.radonc.2021.02.008

N/A

1.4DataRank · unranked

35 citations

Debra A. Goldman, Margaret Hopkins, Attapol Pinitpatcharalert, Sean M. McBride, Daniel Gorovets +9 more

Long-term Outcomes of Local and Metastatic Small Cell Carcinoma of the Urinary Bladder and Genomic Analysis of Patients Treated With Neoadjuvant Chemotherapy

Clinical Genitourinary Cancer(2022)10.1016/j.clgc.2022.05.005

N/A

0.937DataRank · unranked

33 citations

Brendan J. Guercio, Arshi Arora, Xueli Hao, Ashley Marie Regazzi, Timothy F. Donahue +25 more

The oncologic risk of magnetic resonance imaging‐targeted and systematic cores in patients treated with radical prostatectomy

Cancer(2023)10.1002/cncr.34981

N/A

0.442DataRank · unranked

18 citations

Amy L. Tin, Jonathan Fainberg, Samson W. Fine, Ghalib Jibara, Karim Touijer +6 more

MRI-Detectability of Clinically Significant Prostate Cancer Relates to Oncologic Outcomes After Prostatectomy

Clinical Genitourinary Cancer(2022)10.1016/j.clgc.2022.04.001

N/A

0DataRank · unranked

28 citations

Robert A. Lefkowitz, Yulia Lakhman, Joshua Chaim, Ines Nikolovski, Evis Sala +6 more

Outcomes of Grade Group 2 and 3 Prostate Cancer on Initial Versus Confirmatory Biopsy: Implications for Active Surveillance

European Urology Focus(2022)10.1016/j.euf.2022.12.008

N/A

0DataRank · unranked

9 citations

Ghalib Jibara, Amy L. Tin, Samuel Haywood, Daniel D. Sjoberg, Nicole Benfante +9 more

Ganglioneuroblastoma intermixed: Clinicopathological implications of diagnosis at presentation and genomic correlations

Pediatric Blood & Cancer(2023)10.1002/pbc.30434

N/A

0DataRank · unranked

5 citations

Shakeel Modak, Fiorella Iglesias Cardenas, Judy Sarungbam, S. Joseph Sirintrapun, Anuradha Gopalan +6 more

L1 Cell Adhesion Molecule (L1CAM) Expression and Molecular Alterations Distinguish Low-Grade Oncocytic Tumor From Eosinophilic Chromophobe Renal Cell Carcinoma

Modern Pathology(2024)10.1016/j.modpat.2024.100467

N/A

0DataRank · unranked

21 citations

Jie‐Fu Chen, Achim A. Jungbluth, Sirma H. Koutzaki, Matthew B. Palmer, Hikmat Al‐Ahmadie +8 more

Differential NEUROD1, ASCL1, and POU2F3 Expression Defines Molecular Subsets of Bladder Small Cell/Neuroendocrine Carcinoma With Prognostic Implications

Modern Pathology(2024)10.1016/j.modpat.2024.100557

N/A

0DataRank · unranked

17 citations

Karissa Whiting, Min-Yuen Teo, Jacob E. Tallman, Gamze Gokturk Ozcan, Merve Başar +21 more

Amount of Gleason Pattern 3 Is Not Predictive of Risk in Grade Group 2–4 Prostate Cancer

European Urology(2024)10.1016/j.eururo.2024.01.005

N/A

0DataRank · unranked

9 citations

Melissa Assel, Matthew R. Cooperberg, Samson W. Fine, Scott E. Eggener, Andrew J. Vickers

Quantification of Gleason Pattern 4 Metrics Identifies Pathologic Progression in Patients With Grade Group 2 Prostate Cancer on Active Surveillance

Clinical Genitourinary Cancer(2024)10.1016/j.clgc.2024.102204

N/A

0DataRank · unranked

8 citations

Melissa Assel, Sunny Nalavenkata, Sari Khaleel, Nicole Benfante, Sigrid Carlsson +9 more

Targeted Ablation Using Ultrasound-Guided Irreversible Electroporation of Index Tumors (TARGET Study): Prospective Development Study Evaluating Safety, Patient-Reported Outcomes, and Oncologic Efficacy

Urology Practice(2024)10.1097/upj.0000000000000666

N/A

0DataRank · unranked

1 citations

Taehyoung Lee, Emily Vertosick, Arjun Sivaraman, Gregory T. Chesnut, Samson W. Fine +4 more

Clinical Outcomes, Genomic Heterogeneity, and Therapeutic Considerations Across Histologic Subtypes of Urothelial Carcinoma

European Urology(2025)10.1016/j.eururo.2025.04.008

N/A

0DataRank · unranked

22 citations

Ziyu Chen, Karissa Whiting, Irina Ostrovnaya, Andrew T. Lenis, Timothy N. Clinton +26 more

Three Things About Gleason Grading That Just About Everyone Believes But That Are Almost Certainly Wrong

Urology(2020)10.1016/j.urology.2020.03.042

N/A

0DataRank · unranked

9 citations

Samson W. Fine, Andrew J. Vickers

Evaluating Tumor Quantification in Place of Proportions in Prostate Cancer: Principles of the ProQuant Group

European Urology(2025)10.1016/j.eururo.2025.11.013

N/A

0DataRank · unranked

0 citations

Samson W. Fine, Jorg R. Oddens, Auke Jager, Arnoud W. Postema, Harrie P. Beerlage +86 more

Defining the index lesion for potential salvage partial or hemi-gland ablation after radiation therapy for localized prostate cancer

Urologic Oncology Seminars and Original Investigations(2021)10.1016/j.urolonc.2021.01.011

N/A

0DataRank · unranked

4 citations

Amy L. Tin, Arjun Sivaraman, Toshikazu Takeda, Taehyoung Lee, Jonathan Fainberg +11 more

Large cell neuroendocrine carcinoma of the urothelial tract (LNEC): The MSKCC experience.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.4526

N/A

0DataRank · unranked

5 citations

Jatin Gandhi, Min Yuen Teo, Michael Lattanzi, Samuel A. Funt, David H. Aggen +14 more